British racing car company and GlaxoSmithKline team up on a winning formula for innovation.
Partnerships and strategic agreements are common in the pharma industry. But one particular announcement last month gave me cause to raise my eyebrows and smile.
Rich Whitworth
I like fast cars and so too, it would seem, does GlaxoSmithKline's CEO Andrew Witty because the company is embarking on a long-term strategic partnership with the McLaren group, which is best known for its Formula 1 racing cars. The phrase "best of British" springs to mind and both companies seem extremely proud of the partnership.
The aim for GSK? Applying McLaren's engineering and technical expertise to production lines to reduce breakdowns and improve costs, amongst other things.
A state-of-the-art facility planned for 2013 called The McLaren GSK Centre for Applied Performance will allow scientists, engineers, and technologists from both camps to share ideas and collaborate on innovative, dynamic, and exciting joint working projects.
The R&D organization will examine whether real-time monitoring technologies can be applied to human studies. Meanwhile, the GSK Consumer Healthcare business will work with McLaren's "Mission Control" unit to enable faster responses to competitor activity and customer needs.
Some might say that it smacks of a marketing stunt, but which pharma company wouldn't want to be associated with such a fast-paced, exciting, technologically advanced, continually improving world?
What next? Sanofi and Red Bull Racing? The race to the checkered flag is on!
Rich Whitworth is an editor of Pharmaceutical Technology.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.